title: Antagonistic effects of atipamezole, yohimbine and prazosin on medetomidine-induced diuresis in healthy cats.
abstract: This study aimed to investigate and compare the antagonistic effects of atipamezole, yohimbine and prazosin on medetomidine-induced diuresis in healthy cats. Five cats were repeatedly used in each of the 9 groups. One group was not medicated. Cats in the other groups received 40 µg/kg medetomidine intramuscularly and saline (as the control), 160 µg/kg prazosin, or 40, 160 or 480 µg/kg atipamezole or yohimbine intravenously 0.5 hr later. Volume, pH and specific gravity of urine; plasma arginine vasopressin (AVP) level; and creatinine, osmolality and electrolyte levels in both urine and plasma were measured. Both atipamezole and yohimbine, but not prazosin, antagonized medetomidine-induced diuresis. The antidiuretic effect of atipamezole was more potent than that of yohimbine, but was not dose dependent, in contrast to the effect of yohimbine at the tested doses. Both atipamezole and yohimbine reversed medetomidine-induced decreases in both urine specific gravity and osmolality and increases in plasma osmolality and free-water clearance. Antidiuresis of either atipamezole or yohimbine was not related to the area under the curve for AVP level, although the highest dose of both atipamezole and yohimbine initially and temporarily increased plasma AVP levels, suggesting that this may partly influence the antidiuretic effects of both agents. The diuretic effect of medetomidine in cats may be mediated by α2-adrenoceptors, but not α1-adrenoceptors. Atipamezole and yohimbine can be used as antagonistic agents against medetomidine-induced diuresis in healthy cats.
authors.affiliation: Laboratory of Veterinary Internal Medicine, Joint Department of Veterinary Medicine, Faculty of Agriculture, Tottori University, 4-101 Koyama-Minami, Tottori 680-8553, Japan.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Murahata
authors.forename: Asami
authors.initials: A
authors.lastname: Yamamoto
authors.forename: Yuya
authors.initials: Y
authors.lastname: Miki
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Hikasa
mesh_terms: D000818:Animals; D019540:Area Under Curve; D001127:Arginine Vasopressin / Q000097:blood; D002415:Cats / Q000502:physiology*; D003404:Creatinine / Q000097:blood; D004231:Diuresis / Q000187:drug effects* / Q000502:physiology; D004573:Electrolytes / Q000097:blood / Q000652:urine; D006863:Hydrogen-Ion Concentration; D007093:Imidazoles / Q000494:pharmacology*; D020926:Medetomidine / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D009994:Osmolar Concentration; D011224:Prazosin / Q000494:pharmacology*; D013046:Specific Gravity; D016482:Urinalysis / Q000662:veterinary; D015016:Yohimbine / Q000494:pharmacology*
chemical_list: D004573:Electrolytes; D007093:Imidazoles; C050701:atipamezole; D001127:Arginine Vasopressin; D015016:Yohimbine; D003404:Creatinine; D020926:Medetomidine; D011224:Prazosin